Lipodystrophy Syndrome in HIVChristine A. Wanke, Sherwood L. Gorbach Springer Science & Business Media, 06/12/2012 - 233 من الصفحات The evolution ofdata about the HIV-Associated Lipodystrophy Syndrome has been rapid. The syndrome itself is complex and controversial. Although great progress has been made in understanding epidemiology and etiology of the syndrome, much about the syndrome remains mysterious. It was our intention to assist HIV providers with a framework for understanding the status and complexities ofthe field. Each author was requested to provide an evidence-based discussion of a topic for which they have expertise. While it is impossible that such a volume be completely comprehensive, we believe that the approach of this book will allow the reader to develop a relatively complete snapshot of the syndrome. We also believe that the reader of this volume will be able to confront the emerging literature on the HIV-associated lipodystrophy syndrome with a critical eye and that the volume will provide a context in which to place additional data as they are published. |
ما يقوله الناس - كتابة مراجعة
لم نعثر على أي مراجعات في الأماكن المعتادة.
المحتوى
| 1 | |
Body Composition in HIV Lipodystrophy | 21 |
Methods for Assessing Body Composition in HIVAssociated | 38 |
Lipodystrophy 39 | 55 |
Abnormalities in Lipid Metabolism in HIV | 87 |
Pathogenesis of HIV Lipodystrophy | 107 |
Nutrition and Metabolism in HIV1Infected Children Receiving | 138 |
Treatment of Hyperlipidemia and Insulin Resistance with Diet | 169 |
طبعات أخرى - عرض جميع المقتطفات
عبارات ومصطلحات مألوفة
adipocyte adipose tissue adults AIDS associated body composition body shape changes buffalo hump carbohydrate cardiovascular disease cells central fat cholesterol levels Clin Endocrinol Metab Clin Nutr clinical controls decreased diabetes mellitus dietary dyslipidemia effects elevated evaluated fat accumulation fat atrophy fat wasting fiber glucose tolerance glycemic index HAART HAART Therapy Hadigan HIV patients HIV protease inhibitors HIV-1-infected children HIV-associated lipodystrophy HIV-infected patients human immunodeficiency virus hyperinsulinemia hyperlipidemia hypertriglyceridemia immunodeficiency virus infection increased indinavir insulin resistance insulin sensitivity intake intervention Kotler DP LDL cholesterol lipid lipoatrophy lipoprotein liver measurements medications metabolic abnormalities metformin mg/dL mitochondrial toxicity mtDNA NIDDM NRTI nutritional obesity omega-3 fatty acids patients with HIV Pediatr peripheral fat prevalence protein ratio redistribution regimens reported Resistance with Diet reverse transcriptase inhibitors risk factors ritonavir Saint-Marc serum stavudine studies subcutaneous fat suggest TG levels treatment triglycerides troglitazone visceral adipose tissue visceral fat VLDL women
